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Abstract  
Background: Toxic hepatitis may clinically manifest as other diseases of the liver, where it must 
always be considered in differential diagnoses of unexplained liver damage, such as poisoning with 
kombucha tea.  
Case report: 47-year old female patient was hospitalized and has consumed daily ounces of 
kombucha tea. During hospitalization patient was diagnosed with toxic hepatitis and treated with 
intravenous solutions of hepatic protective and ursodeoxycholic-acid (effective therapy).   
Conclusion: Examinations showed that kombucha tea has potential to revert the CCl4-induced 
hepatic toxicity, but used in overdose can induce toxicity himself.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Investigation of adverse reactions toxic 
substances in the liver is a challenge of modern 
hepatology. It should not be forgotten that toxic 
hepatitis may clinically be manifested as other 
diseases of the liver, where it must always be 
considered in the differential diagnoses of 
unexplained liver damage in poisoning with the 
kombucha tea.  The pathogenesis and mechanism of 
liver damage in most of toxins is unknown. It may be 
experienced as an allergic and/or toxic reaction. 
Considering that various microorganisms already 
habituate on kombucha, between those are acid 
bacteria's (from apple acid used for preparing) which 
are using the oxygen, and from the other side we 
have yeasts which are facultative anaerobes.  
There is no specific clinical picture of hepatic 
toxicity of the substance or the drug. It is presented by 
nausea, vomiting, abdominal pain, diarrhea, jaundice, 
rash, cholecystitis, neurotoxicity, etc. During 
hospitalization our patient was diagnosed with toxic 
hepatitis and treated with intravenous solutions of 
hepatic protective and ursodeoxycholic-acid as the 
effective therapy.   
Kombucha (Japanese, Russian, Chinese, 
Indian mushroom, mushroom for longevity, karga - 
tea, cembua orientals) tea is sugared black tea 
fermented with a symbiotic culture of acetic acid 
bacteria and yeasts. Tea fungus symbiosis actually 
makes two types of organisms: fungi (yeasts) and 
acetic-acid bacteria (bacterium dzylinum and gluconic, 
Acetobacter ketogenum, Pichia fermentantsa). Yeasts 
produce alcohol from sugar and alcohol use bacteria 
as source of energy and convert it into acetic acid. 
When yeasts convert sucrose into glucose and 
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fructose, allowing bacteria to produce gluconic acid 
and which protects the yeasts from competing 
microorganisms. It is built in the form of multi-layer 
membrane, grayish in color and it is not eatable. The 
kombucha is called thick, slimy, brown cover jelly 
mass that floats on the surface of sweetened liquid, 
which after fermentation is used as a tea drink [1].  
 The tea is gluconic acid, which under normal 
metabolic conditions is produced by the human liver. 
The acid goes directly into the blood and has 
protective role for the human body [1, 2]. Besides the 
hepatic toxicity it is possible for other unfavorable 
effects to appear such as gastrointestinal and other 
systemic pathology, caused by the way of preparation 
and consumption as well as because of negative 
interrelation with other medication.  
Increasing the acid leads to excessive 
acidification of blood, which may produce changes in 
the balance of the body, and in severe cases can 
even cause death [3, 4]. 
Kombucha tea is claimed to have various 
beneficial effects on human health, but there is very 
little scientific evidence, to support this claim, 
available in the literature. Examinations showed that 
kombucha tea has the potential to revert the CCl4-
induced hepatic toxicity. Antioxidant molecules 
produced during the fermentation period could be the 
reason for the efficient hepatic protective and curative 
properties of kombucha tea against CCl4-induced 
hepatic toxicity, but used in overdose can induce 
toxicity himself.  Hystopathological analysis of liver 
tissue, obtained through biopsy, was important in the 
clinical diagnoses and causal therapy [3, 4]. 
 
Case report 
A 47-year old female patient was initially 
hospitalized at Clinic for infectious diseases of Clinical 
Centre (Central Serbia) with nausea, fatigue, yellow 
discoloration of the skin and visible mucous 
membranes, dark discoloration of urine and discrete 
neurological problems (anxiety, agitation). Problems 
have appeared suddenly four days before admission. 
Problems have initially been reported to the first 
doctor, who had suspected acute hepatitis due to 
infectious diseases. When infectious diseases had 
been excluded, due to elevated hepatogram and 
cellular necrosis of the liver and muscle, the patient 
was transferred to the Clinic of gastroenterology in 
same Clinical Centre.  Anamneses excluded earlier 
acute and chronic diseases, without previously taking 
any treatment. Subsequently, the obtained data, that 
patient had consumed daily ounces of kombucha tea, 
during past two years.  
Clinical review has showed yellow skin 
discoloration aka icterus, finding on the heart 
indicated a slight systolic murmur over the aorta, other 
systems examinations were regular. There is no 
typical clinical picture of liver damage toxins and/or 
drugs, but is presenting with a broad specter of 
differential diagnosis of clinical entities. 
In laboratory analyzes normal blood-work was 
registered: negative inflammatory syndrome, elevated 
liver parameters and muscle necrosis, elevated levels 
of Gamma-glutamyltransferase (Gamma GT), total 
and direct bilirubins, normal ionogram, negative 
markers for viral diseases, negative tumor marker and 
immunological analysis.  Electro cardio graphic (ECG) 
recorded sinus rhythm in frequency of 80/min. Chest 
radiography was regular. Abdominal ultrasound, 
endoscopy of the esophagus, stomach and duodenum 
were without characteristics. After consulting 
hematologist, the complete hematological analyses 
had been performed and other hematological 
diseases were ruled out.  
Determining the values of copper and 
ceruloplasmin in 24 hour-urine, clinics ruled out the 
Wilsons’ (hepatolenticulare disease). The absence of 
antimikrozomal antibodies ruled out the primary biliary 
cirrhosis in the differential diagnosis of liver diseases. 
Diagnosis of the toxic hepatitis can be set, when all 
other diseases of the liver are being excluded. During 
the hospitalization, the patient was treated with 
intravenous solutions of hepatoprotective and 
ursodeoxycholic-acid. The patient was discharged 
after 23 days of hospitalization partially recovered, 
with elevated inflammatory parameters of muscle and 
liver, as well as bilirubin, Gamma GT, which are 
decreasing compared to the initial results. At the first 
control after seven days parameters are still 
decreasing, the second control after two weeks, and 
the third after one month also showed decrease in the 
analyses but not total recovery. On the fourth control 
after two months, all parameters were benchmarks: 
total bilirubin - 150.5, (ref. 5-21 µmol/L); direct bilirubin 
- 91.2, (ref. 0.1-3.4 µmol/L); AST – 1288, (ref. 0-40 
IU/L); ALT – 2163, (ref. 0-40 IU/L); Gamma GT- 608 
(ref. 7-50 IU/L) and LDH – 1111, (ref. 220-450 U/L) 
(Table 1). 
 
Table1: Elevated biochemical parameters and reference values 
of toxic hepatitis with kombucha tea. 
Laboratory analysis 
(unit) 
Initial values 
(reference 
values) 
 
Values 
during 
hospita-
lization 
First 
control 
Fourth 
control 
AST (IU/L) 1288 (0-40) 815 87 40 
ALT (IU/L) 2163 (0- 40) 1658 201 47 
CK (U/L) 1646 (0-171) 759 24 22 
CK-MB (U/L) 455 (<25) 419 179 15 
LDH (U/L) 1111 (220-450) 495 420 242 
Total bilirubin (μmol/L)  150.5 (<21) 90.3 29.8 9.5 
Direct bilirubin (μmol/L) 91.2 (0.1–3.4) 47.4 11.0 1.2 
Gamma GT (IU/L) 608 (7-50) 545 209 39 
Legend:AST - aspartate transaminase; ALT - alanine transaminase; CK - creatine kinase; 
CK-MB - creatine phosphokinase; LDH - lactate dehydrogenase; Gamma GT - Gamma-
glutamyltransferase. 
 
Due to the normalization of the liver function 
parameters and the causal toxic hepatitis caused by 
kombucha tea, patient was not submitted to the liver 
biopsy. 
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Discussion 
Kombucha tea is sugared black tea fermented 
with the symbiotic culture of acetic acid bacteria and 
yeasts as tea fungus. It is claimed to have various 
beneficial effects on human health, but there is very 
little scientific evidence available in the domestic and 
world literature. 
Consumption of Kombucha tea as potentially 
damaging factor in individual concentration can cause 
hepatitis (when other factors are being eliminated), 
with clear pathogenesis of hepatitis correlated with 
using of Kombucha tea. 
Kombucha tea along with black tea and black 
tea manufactured with tea fungus enzymes (enzyme-
processed tea) was evaluated for hepatic protective 
and curative properties against CCl4-induced toxicity, 
using male albino rats as an experimental model by 
analyzing aspartate transaminase, alanine 
transaminase, gamma-glutamyltransferase, creatine 
kinase, creatine phosphokinase, lactate 
dehydrogenize and alkaline phosphatase in plasma 
and malondialdehyde content in plasma and liver 
tissues (hystopathological analysis of liver tissue, 
obtained through biopsy, was necessary). 
Results showed that kombucha tea has the 
potential to revert the CCl4-induced hepatic toxicity. 
Antioxidant molecules produced during the 
fermentation period could be the reason for the 
efficient hepatic protective and curative properties of 
kombucha tea against CCI4-induced hepatic toxicity 
[1, 2].  
NONI-juice (Morinda citrifolia) is an 
increasingly popular wellness drink claimed to be 
beneficial for many illnesses. Many authors present 
cases of novel hepatic toxicity of NONI-juice. Routine 
laboratory tests and the liver biopsy were performed. 
The most likely hepatic toxic components of Morinda 
citrifolia were anthrax-quinones. Physicians should be 
aware of potential hepatic toxicity of NONI-juice as the 
one of toxic-plant [5, 6].  
Herbal medicines can cause abnormal test 
results and confusion in proper diagnosis (test results 
by direct interference with certain immunoassays). For 
example, kava-kava can cause drug-induced 
hepatitis, leading to unexpected high concentrations 
of liver enzymes. Many toxic effects of herbal 
medicines include cardiovascular toxic effects, 
hematological toxic effects, neurological toxic effects, 
nephro-toxic effects, carcinogenic effects and few 
allergic reactions [7]. 
The review is based on search of literatures 
using herbs and herbal traditional Chinese medicines 
with toxicity. It is included high variability in 
active/toxic ingredients due to growing conditions, use 
of inherent toxic herbs causing toxicity, overdose of 
herbs, drug-herb interactions especially with 
pharmaceuticals that have narrow therapeutic index, 
coexisting diseases and idiosyncratic reactions like 
allergy, hepatitis and anaphylaxis, our patient crossed 
the line of health in toxicity by overdosing with 
kombucha tea [8]. 
Many results obtained during the examination 
could conclude that M. corchorifolia aerial part 
extracts have antioxidant and hepatic protective 
components. Further examination is necessary for 
isolation and characterization of bioactive molecules 
which are responsible for hepatic protective and 
antioxidant activity, what may open a new research 
topic in our future trials [9].  
The glycoside, alkaloid, oxalate, tox-albumin, 
saponin, terpene and terpenoid containing plants were 
recorded and found to be responsible for intoxication 
in animals and humans. Epidemiological data from an 
Italian survey provide useful information on animal 
exposure to plants and confirm the importance of 
plants as causative agents of animal poisoning [10]. 
Herbal hepatic toxicity isn’t uncommonly 
encountered, but precise incidence and 
manifestations have not been well characterized. The 
clinical presentation and severity can be highly 
variable, ranging from mild hepatitis to acute hepatic 
failure requiring transplantation. Scoring systems for 
causality assessment of drug-induced liver injury may 
be helpful, but have not been validated for herbal 
hepatic toxicity. Hepatic toxicity features of commonly 
used herbal products, such as clinic significant herb-
drug interactions are discussed. A number of herbal 
medicinal products are associated with the spectrum 
of hepatic toxicity events. Advances in the 
understanding of the pathogenesis and the risks 
involved are needed to improve herbal medicine 
safety; something authors have experienced 
themselves, and whose opinion authors also share 
[11]. 
Hepatic encephalopathy is the serious 
complication of toxic hepatitis. Health-related quality 
of life (HR-QOL) is impaired in this patients and 
represents an important outcome measure for further 
therapy. Assessments included mean changes in the 
severity of hepatic encephalopathy - related 
symptoms, changes in disease severity (measured on 
the modified Clinical Global Impression-Severity 
scale), and changes in disease status (measured on 
the modified scale). Patient self-assessment 
correlated well with the physicians' clinical evaluation. 
Treatment of toxic hepatitis with oral L-ornithine-L-
aspartate in patients markedly improved HR-QOL and 
was well tolerated by patients [3]. 
The domestic and world authors reported that, 
while kombucha tea is considered a healthy elixir, the 
limited evidence currently available raises 
considerable concern that it may pose a serious treat 
for health. Consumption of the kombucha tea should 
be discouraged, as it may be associated with life-
threatening lactic-acidosis and toxic hepatitis, what 
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was the topic or this article research and will continue 
to research in some of future articles [4]. 
In a conclusion, Kombucha tea is claimed to 
have various beneficial effects on human health, but 
there is very little scientific evidence available in 
literature. Even though Kombucha tea is not safe for 
mass using for it may cause toxic hepatitis, which can 
be confirmed in laboratory, examinations showed that 
kombucha tea has the potential to revert the CCl4-
induced hepatic toxicity. Antioxidant molecules 
produced during the fermentation period could be the 
reason for the efficient hepatic protective and curative 
properties of kombucha tea against CCl4-induced 
hepatic toxicity, but even so is true used in overdose 
can induce toxicity himself. Diagnosis of the toxic 
hepatitis can be set only if all other diseases of the 
liver are properly excluded. Effective therapy was with 
intravenous solutions of hepatic protective and 
ursodeoxycholic-acid. Hystopathological analysis of 
liver tissue, obtained through biopsy, was important in 
clinical diagnoses and causal, known therapy [3, 4]. 
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